| Completed | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Co N/A, as no Specific Medical Condition Will be Treated | Phase 1 | 2022-10-19 |
| Completed | A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treat Essential Tremor of the Upper Limb | Phase 2 | 2021-02-24 |
| Active Not Recruiting | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower L Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury | Phase 3 | 2019-09-16 |
| Completed | Local Study of Akatinol Memantine in VaD in Russia Vascular Dementia | Phase 3 | 2018-01-23 |
| Completed | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips V Subjects Desiring Lip Augmentation | N/A | 2017-08-16 |
| Completed | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face Correction of Facial Wrinkles/Folds, Facial Volume Enhancement | — | 2016-06-01 |
| Completed | Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chroni Chronic Troublesome Sialorrhea, Cerebral Palsy, Stroke | Phase 3 | 2015-02-09 |
| Completed | Botulinum Toxin A to Treat Arm Tremor Essential Tremor of the Upper Limbs | Phase 2 | 2014-12-05 |
| Completed | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatr Cerebral Palsy, Spastic Paraplegia and Hemiparesis, Equine and Equinovarus Foot Deformation | Phase 2 | 2014-07-01 |
| Completed | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea, Parkinson's Disease, Post-stroke | Phase 3 | 2014-04-01 |
| Completed | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of A Cerebral Palsy, Spasticity | Phase 3 | 2014-03-28 |
| Completed | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of Bilateral Blepharospasm (BEB) | Phase 3 | 2013-11-01 |
| Completed | Effectiveness and Safety Study of Overnight Intensive Patch in Scars Post Dermatological Surgery Scars | N/A | 2013-10-01 |
| Completed | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebra Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy | Phase 3 | 2013-08-01 |
| Completed | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cere Lower Limb Spasticity Due to Cerebral Palsy | Phase 3 | 2013-06-01 |
| Completed | Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients Healthy Volunteers and Glaucoma Patients | Phase 1 | 2012-10-01 |
| Completed | Blepharospasm Patient Survey for Patients With Blepharospasm Blepharospasm | — | 2012-09-01 |
| Completed | Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm Spasticity of the Upper and Lower Limb Due to Cerebral Causes | Phase 3 | 2012-05-01 |
| Completed | A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs Female Pattern Hair Loss, Androgenetic Alopecia (AGA), Ludwig Type 1 | Phase 2 | 2012-04-01 |
| Completed | Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dysto Cervical Dystonia | Phase 4 | 2012-01-20 |
| Terminated | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring Habitual Snoring | Phase 2 | 2012-01-01 |
| Completed | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Str Post-stroke Spasticity of the Lower Limb | Phase 3 | 2011-12-01 |
| Completed | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Str Post-stroke Spasticity of the Upper Limb | Phase 3 | 2011-09-01 |
| Completed | Contractubex Treatment in Scars After Abdominal Caesarean Section Scars | Phase 4 | 2011-02-01 |
| Completed | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 Physiological Stress, Disorder of Aging, Skin Diseases | Phase 4 | 2011-02-01 |
| Completed | Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment | Phase 2 | 2010-11-01 |
| Completed | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy M Metabolism of Neramexane | Phase 1 | 2010-04-01 |
| Withdrawn | Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorder Sleep-Disordered Breathing | Phase 2 | 2010-03-01 |
| Completed | Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application Healthy | Phase 1 | 2009-10-01 |
| Completed | Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Durat Healthy Subjects | Phase 1 | 2009-09-01 |
| Completed | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus Subjective Tinnitus | Phase 3 | 2009-09-01 |
| Completed | Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesyla Healthy | Phase 1 | 2009-09-01 |
| Completed | Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate Healthy | Phase 1 | 2009-08-01 |
| Completed | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administratio Healthy Subjects | Phase 1 | 2009-07-01 |
| Completed | Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradi Healthy | Phase 1 | 2009-06-01 |
| Terminated | Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Nystagmus, Congenital, Nystagmus, Acquired, Multiple Sclerosis | Phase 2 | 2009-05-01 |
| Terminated | Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramex Subjective Tinnitus | Phase 3 | 2009-01-01 |
| Completed | Memantine and Validation of a New Alzheimer's Disease Scale Alzheimer's Disease | Phase 3 | 2008-12-01 |
| Completed | Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus Subjective Tinnitus | Phase 3 | 2008-11-01 |
| Completed | NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabella Glabellar Frown Lines | Phase 3 | 2008-11-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines Moderate to Severe Glabellar Frown Lines | Phase 3 | 2008-10-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 Moderate to Severe Glabellar Frown Lines | Phase 3 | 2008-10-01 |
| Completed | Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus Subjective Tinnitus | Phase 3 | 2008-09-01 |
| Completed | Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines Healthy | Phase 1 | 2008-07-01 |
| Terminated | Memantine and Antipsychotics Use Alzheimer's Disease | Phase 4 | 2008-07-01 |
| Completed | Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines Healthy | Phase 3 | 2008-05-01 |
| Completed | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus Nystagmus, Congenital Idiopathic, Nystagmus, Acquired | Phase 2 | 2008-05-01 |
| Completed | Memantine - Communication Study Alzheimer's Disease | Phase 3 | 2007-11-01 |
| Completed | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Cervical Dystonia | Phase 4 | 2007-09-01 |
| Completed | Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles Lateral Periorbital Wrinkles | Phase 3 | 2007-09-01 |
| Completed | Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products Healthy | Phase 1 | 2007-08-01 |
| Terminated | Blepharospasm Short Interval Blepharospasm | Phase 2 | 2007-08-01 |
| Completed | Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines Glabellar Lines | Phase 3 | 2007-06-18 |
| Completed | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity Upper Limb Spasticity | Phase 3 | 2007-02-01 |
| Completed | Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines Glabellar Frown Lines | Phase 2 | 2006-11-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines Glabellar Frown Lines | Phase 3 | 2006-10-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm Blepharospasm | Phase 3 | 2006-10-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia Cervical Dystonia | Phase 3 | 2006-07-01 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb Post-stroke Upper Limb Spasticity | Phase 3 | 2006-06-01 |
| Completed | Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds Nasolabial Folds | Phase 4 | 2005-12-01 |
| Completed | Neramexane for Tinnitus Tinnitus | Phase 2 | 2005-10-01 |